Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction, Volume II

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2023 May 31

PMID 37255962

Authors

Stefania Chiappini

Fabrizio Schifano

Giovanni Martinotti

Affiliations

Soon will be listed here.

Citing Articles

Dispensing of zolpidem and benzodiazepines in Brazilian private pharmacies: a retrospective cohort study from 2014 to 2021.

Carvalho F, Tonon A, Hidalgo M, Costa M, Mengue S Front Pharmacol. 2024; 15:1405838.

PMID: 39588152 PMC: 11586159. DOI: 10.3389/fphar.2024.1405838.

References

Reeves R, Ladner M, Perry C, Burke R, Laizer J . Abuse of medications that theoretically are without abuse potential. South Med J. 2015; 108(3):151-7. DOI: 10.14423/SMJ.0000000000000256. View

Schifano F . Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon. Brain Sci. 2018; 8(12). PMC: 6316773. DOI: 10.3390/brainsci8120221. View

Zaami S, Marinelli E, Vari M . New Trends of Substance Abuse During COVID-19 Pandemic: An International Perspective. Front Psychiatry. 2020; 11:700. PMC: 7378810. DOI: 10.3389/fpsyt.2020.00700. View

Victorri-Vigneau C, Gerardin M, Rousselet M, Guerlais M, Grall-Bronnec M, Jolliet P . An update on zolpidem abuse and dependence. J Addict Dis. 2014; 33(1):15-23. DOI: 10.1080/10550887.2014.882725. View

Chiappini S, Mosca A, Miuli A, Semeraro F, Mancusi G, Santovito M . Misuse of Anticholinergic Medications: A Systematic Review. Biomedicines. 2022; 10(2). PMC: 8962297. DOI: 10.3390/biomedicines10020355. View

Orsolini L, Chiappini S, Grandinetti P, Bruschi A, Testa R, Provenzano A . 'Z-trip'? A Comprehensive Overview and a Case-series of Zolpidem Misuse. Clin Psychopharmacol Neurosci. 2021; 19(2):367-387. PMC: 8077048. DOI: 10.9758/cpn.2021.19.2.367. View

Martinotti G, Alessi M, Di Natale C, Sociali A, Ceci F, Lucidi L . Psychopathological Burden and Quality of Life in Substance Users During the COVID-19 Lockdown Period in Italy. Front Psychiatry. 2020; 11:572245. PMC: 7497905. DOI: 10.3389/fpsyt.2020.572245. View

Chiappini S, Schifano F . What about "Pharming"? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs. Brain Sci. 2020; 10(10). PMC: 7602178. DOI: 10.3390/brainsci10100736. View

Schifano F, Chiappini S, Miuli A, Mosca A, Santovito M, Corkery J . Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants. Front Psychiatry. 2021; 12:657397. PMC: 8138162. DOI: 10.3389/fpsyt.2021.657397. View

10.

Chiappini S, Schifano F, Corkery J, Guirguis A . Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports. J Psychopharmacol. 2021; 35(6):681-692. PMC: 8278560. DOI: 10.1177/0269881120959615. View

11.

Chiappini S, Ceci F, Mosca A, Di Carlo F, Burkauskas J, Pettorruso M . Knowledge and Use of Over-the-counter Drugs in Italy: An Exploratory Survey-based Study in the General Population. Curr Neuropharmacol. 2022; 21(1):133-141. PMC: 10193759. DOI: 10.2174/1570159X20666220714104231. View

12.

Martinotti G, De Risio L, Vannini C, Schifano F, Pettorruso M, Di Giannantonio M . Substance-related exogenous psychosis: a postmodern syndrome. CNS Spectr. 2020; 26(1):84-91. DOI: 10.1017/S1092852920001479. View

13.

Schifano F, Chiappini S, Corkery J, Guirguis A . An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions. Int J Neuropsychopharmacol. 2019; 22(4):270-277. PMC: 6441128. DOI: 10.1093/ijnp/pyz007. View

14.

Chiappini S, Miuli A, Mosca A, Pettorruso M, Guirguis A, John M . The Benzydamine Experience: A Systematic Review of Benzydamine Abuse. Curr Neuropharmacol. 2021; 19(10):1728-1737. PMC: 8977632. DOI: 10.2174/1570159X19666210113151136. View

15.

Simeone R . Doctor Shopping Behavior and the Diversion of Prescription Opioids. Subst Abuse. 2017; 11:1178221817696077. PMC: 5398712. DOI: 10.1177/1178221817696077. View

16.

Alexander G, Stoller K, Haffajee R, Saloner B . An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19. Ann Intern Med. 2020; 173(1):57-58. PMC: 7138407. DOI: 10.7326/M20-1141. View

17.

Schifano F, Chiappini S, Corkery J, Scherbaum N, Guirguis A . The e-psychonaut drugs' psychopharmacology. Curr Opin Pharmacol. 2021; 57:165-174. DOI: 10.1016/j.coph.2021.02.008. View

18.

Chiappini S, Vickers-Smith R, Guirguis A, Corkery J, Martinotti G, Harris D . Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System.... Pharmaceuticals (Basel). 2022; 15(6). PMC: 9231103. DOI: 10.3390/ph15060675. View

19.

Levine D . "Pharming": the abuse of prescription and over-the-counter drugs in teens. Curr Opin Pediatr. 2007; 19(3):270-4. DOI: 10.1097/MOP.0b013e32814b09cf. View

20.

Chiappini S, Guirguis A, John A, Corkery J, Schifano F . COVID-19: The Hidden Impact on Mental Health and Drug Addiction. Front Psychiatry. 2020; 11:767. PMC: 7403495. DOI: 10.3389/fpsyt.2020.00767. View